Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1600 participants.

Also called NCT02208765

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 1,600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02208765
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02208765. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-01 (actual); primary completion 2022-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity
Acronym
EVAPERF
Condition
Coronary Atherosclerosis
Intervention (Device)
Stress Single Photon Emission Computed Tomography
Lead sponsor
University Hospital, Grenoble (class: other)

Record details

Record id
cardio:ct-nct02208765
Content hash
6bf60f7713fc0291f9ee4810d5c5be5a29c9dc78293fc6c719e9708f85c5b2de